VXRT stock forecast
Our latest prediction for Vaxart, Inc.'s stock price was made on the Nov. 7, 2019 when the stock price was at 0.33$.
In the short term (2weeks), VXRT's stock price should outperform the market by 6.62%. During that period the price should oscillate between -10.69% and +21.92%.
In the medium term (3months), VXRT's stock price should outperform the market by 17.64%. During that period the price should oscillate between -21.82% and +72.15%.Get email alerts
About Vaxart, Inc.
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.
At the moment the company generates 8M USD in revenues.
On its last earning announcement, the company reported a loss of -2.27$ per share.
The book value per share is 3.13$
Three months stock forecastNov. 7, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|